FDA Adverse Event Monitoring System (AEMS) FDA is implementing the Adverse Event Monitoring System (AEMS) to consolidate multiple disparate reporting systems currently used across all FDA-regulated […]

FDA Adverse Event Monitoring System (AEMS) FDA is implementing the Adverse Event Monitoring System (AEMS) to consolidate multiple disparate reporting systems currently used across all FDA-regulated […]

Reference #: FEI 3005574978 Product: Drugs Recipient: Recipient Name Mr. Paul Eichholz Recipient Title Vice President of Quality & Regulatory Compliance Bell International Laboratories, Inc. 2950 […]

Date: May 5, 2026 Time: 1:00 p.m. – 2:00 p.m. ET Register Here Visit CDER Small Business and Industry Assistance (SBIA) Homepage The webinar provides an […]

Reference #: FEI 3003395329 Product: Drugs Recipient: Recipient Name Mr. Ronald Scarboro Recipient Title CEO Azurity Pharmaceuticals, Inc. 900 Ridgefield DriveRaleigh, NC 27609United States [email protected] Issuing […]

FDA Adverse Event Monitoring System (AEMS) FDA is implementing the Adverse Event Monitoring System (AEMS) to consolidate multiple disparate reporting systems currently used across all FDA-regulated […]

FDA Adverse Event Monitoring System (AEMS) FDA is implementing the Adverse Event Monitoring System (AEMS) to consolidate multiple disparate reporting systems currently used across all FDA-regulated […]

FDA Adverse Event Monitoring System (AEMS) FDA is implementing the Adverse Event Monitoring System (AEMS) to consolidate multiple disparate reporting systems currently used across all FDA-regulated […]

Delivery Method: VIA UNITED PARCEL SERVICE AND VIA E-MAIL Reference #: 26-HFD-45-03-01 Product: Drugs Recipient: Recipient Name Mr. David S. Moore Recipient Title President Novo Nordisk […]